Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
IJMS | Free Full-Text | CD39 Regulation and Functions in T Cells
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
CD73 expression and activity in serum-derived exosomes. (A) A... | Download Scientific Diagram
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint - eBioMedicine
Cancers | Free Full-Text | The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
CD73, What a Powerful Therapy Target in Tumor Immune
Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer - ScienceDirect
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities: Trends in Cancer
Biomarkers Testing for Bladder Cancer - Enzo Life Sciences
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy | Journal for ImmunoTherapy of Cancer
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors | PNAS
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
CD73, What a Powerful Therapy Target in Tumor Immune
Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma - Shali - 2019 - Journal of Cellular Physiology - Wiley Online Library
The difference of CD73 expression levels in lung cancer tumor tissue... | Download Scientific Diagram
Cancers | Free Full-Text | Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
Frontiers | Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
CD73 is a hypoxia-responsive gene and promotes the Warburg effect of human gastric cancer cells dependent on its enzyme activity
Exosome-Mediated Metastasis: From Epithelial–Mesenchymal Transition to Escape from Immunosurveillance: Trends in Pharmacological Sciences
Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
